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a pragmatic, multicentre, randomised controlled trial
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on behalf of the eTHoS study group*
Summary
Background Two commonly performed surgical interventions are available for severe (grade II–IV) haemorrhoids; 
traditional excisional surgery and stapled haemorrhoidopexy. Uncertainty exists as to which is most eﬀ ective. The 
eTHoS trial was designed to establish the clinical eﬀ ectiveness and cost-eﬀ ectiveness of stapled haemorrhoidopexy 
compared with traditional excisional surgery.
Methods The eTHoS trial was a large, open-label, multicentre, parallel-group, pragmatic randomised controlled trial 
done in adult participants (aged 18 years or older) referred to hospital for surgical treatment for grade II–IV 
haemorrhoids. Participants were randomly assigned (1:1) to receive either traditional excisional surgery or stapled 
haemorrhoidopexy. Randomisation was minimised according to baseline EuroQol 5 dimensions 3 level 
score (EQ-5D-3L), haemorrhoid grade, sex, and centre with an automated system to stapled haemorrhoidopexy or 
traditional excisional surgery. The primary outcome was area under the quality of life curve (AUC) measured with the 
EQ-5D-3L descriptive system over 24 months, assessed according to the randomised groups. The primary outcome 
measure was analysed using linear regression with adjustment for the minimisation variables. This trial is registered 
with the ISRCTN registry, number ISRCTN80061723.
Findings Between Jan 13, 2011, and Aug 1, 2014, 777 patients were randomised (389 to receive stapled haemorrhoidopexy 
and 388 to receive traditional excisional surgery). Stapled haemorrhoidopexy was less painful than traditional 
excisional surgery in the short term and surgical complication rates were similar between groups. The 
EQ-5D-3L AUC score was higher in the traditional excisional surgery group than the stapled haemorrhoidopexy 
group over 24 months; mean diﬀ erence –0·073 (95% CI –0·140 to –0·006; p=0·0342). EQ-5D-3L was higher for 
stapled haemorrhoidopexy in the ﬁ rst 6 weeks after surgery, the traditional excisional surgery group had signiﬁ cantly 
better quality of life scores than the stapled haemorrhoidopexy group. 24 (7%) of 338 participants who received 
stapled haemorrhoidopexy and 33 (9%) of 352 participants who received traditional excisional surgery had serious 
adverse events.
Interpretation As part of a tailored management plan for haemorrhoids, traditional excisional surgery should be 
considered over stapled haemorrhoidopexy as the surgical treatment of choice.
Funding National Institute for Health Research Health Technology Assessment programme.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
Introduction
Haemorrhoids are swellings of the sub mucosal veins at 
the top of the anal canal. Symptoms from haemorrhoids 
include bleeding, pain, prolapse and peri-anal itch with 
prevalence rates of up to 44% within the general 
population.1,2 A substantial proportion of the population 
will have symptoms of haemorrhoids within their 
lifetime and the presence of per-rectal bleeding, and its 
association with colorectal cancer, can cause anxiety.2
The initial management of haemorrhoids is community 
based, where no concern exists about the presence of 
colorectal cancer or inﬂ ammatory bowel disease. Dietary 
manipulation, bulk forming laxatives, and advice should 
be oﬀ ered ﬁ rst. Persistent symptoms merit referral for 
investigation and treatment. Outpatient treatment 
principally involves rubber band ligation for lower grade 
haemorrhoids, whereas surgical interventions are used 
for higher grade haemorrhoids where banding has been 
unsuccessful. Rubber band ligation is a clinic-based 
procedure where a small band is placed at the top of a 
haemorrhoid to reduce its size by interfering with tissue 
blood supply. The widely adopted Goligher system3 for 
grading haemorrhoids was used in this trial.
Given the prevalence of the condition, the 
management of haemorrhoidal disease continues to 
have considerable workload and costs implications for 
the National Health Service (NHS), with approximately 
25 000 haemorrhoidal procedures being performed as 
hospital day-case or inpatient admissions in England in 
2006–07.4 Over the past two decades, understanding of 
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the anatomy of haemorrhoids has improved, leading to 
the introduction of new surgical technologies into 
clinical practice, often without previous robust 
assessment. These technologies included stapled 
haemorrhoidopexy and haemorrhoidal artery ligation, 
variants of which are promoted through surgical 
technology industries. The purported advantages of the 
new treatments, when compared with an existing 
surgical technique, traditional excisional surgery (or 
haemorrhoidectomy), were less postoperative pain with 
similar symptom control.5
Despite numerous small-scale randomised controlled 
trials, signiﬁ cant doubts remain about the usefulness, 
eﬃ  ciency, and cost-eﬀ ectiveness of stapled haem-
orrhoid opexy and haemorrhoidal artery ligation.6 
Evidence synthesised in systematic reviews and Health 
Technology Assessments7–13 has highlighted the lack of 
good quality data on which to base management 
choices. This led to the National Institute of Health 
Research commissioning two trials to perform robust 
assessments of the newer techniques (eTHoS and 
haemorrhoidal artery ligation vs rubber band ligature 
for the management of symptomatic grade II and III 
haemorrhoids [HubBLe]). The HubBLe trial recently 
reported its results which compared haemorrhoidal 
artery ligation with rubber band ligature. Although a 
small overlap exists between HubBLe and eTHoS, the 
trials were designed to dovetail together with less 
advanced disease falling mainly into the HubBLe trial 
and more advanced disease eligible for eTHoS. The 
authors of HubBLe concluded that if rubber band 
ligature was considered as a course of treatment, 
recurrence rates of haemorrhoids were similar to that 
with haemorrhoidal artery ligation, and haemorrhoidal 
artery ligation was more expensive and not 
cost-eﬀ ective.14 The aim of the eTHoS trial was to assess 
whether stapled haemorrhoidopexy was more eﬀ ective 
and cost-eﬀ ective compared with traditional excisional 
surgery in the treatment of grade II, III, and IV 
haemorrhoids. The primary objective was to compare 
health-related quality of life derived over 24 months.
Methods
Study design and participants
The eTHoS trial was a large, open-label, multicentre, 
parallel-group, pragmatic randomised controlled trial 
done in 32 UK NHS hospitals. Potential participants were 
adults aged 18 years or older referred to hospital for 
surgical treatment for haemorrhoids. Patients with 
haemorrhoids (grade II–IV), who provided written 
informed consent, were eligible to take part. Participants 
referred to hospital with haemorrhoids were included in 
the trial if their symptoms were refractory to rubber band 
ligature or haemorrhoidal artery ligation or if their 
haemorrhoids were thought to be too large for these 
treatments to be successful. Those precluded from the 
trial included patients who had previous surgery for 
haemorrhoids (traditional or stapled) and those who had 
Research in context
Evidence before this study
A Health Technology Assessment evidence synthesis and 
six systematic reviews published between 2006 and 2015 have 
assessed the role of stapled haemorrhoidopexy versus traditional 
excisional surgery. Over 50 randomised controlled trials have 
been conducted of variable size and quality. These studies have 
suggested short-term pain was higher with traditional excisional 
surgery than stapled haemorrhoidopexy though recurrence was 
also higher with stapled haemorrhoidopexy. Previous economic 
assessments of these operations were based on limited quality 
of life data, and suggested a shorter operation time for stapled 
haemorrhoidopexy than traditional excisional surgery. There was 
also a paucity of medium-to-long-term clinical and economic 
data regarding stapled haemorrhoidopexy or traditional 
excisional surgery particularly for grade II haemorrhoids. 
Added value of this study
We did a large multicentre, open-label, randomised controlled 
trial of 777 patients comparing stapled haemorrhoidopexy 
with traditional excisional surgery. To our knowledge, this is 
the largest trial of this treatment comparison for 
haemorrhoids. The overall quality of life was signiﬁ cantly 
better for the traditional excisional group than the stapled 
haemorrhoidopexy group over 24 months (–0·073 [95% CI 
–0·140 to –0·006]; p=0·0342). Participants in the traditional 
excisional surgery group had fewer symptoms at 12 and 
24 months (both p<0·0001) and reported fewer recurrences at 
12 (39/278) and 24 months (76/300) compared with the 
stapled haemorrhoidopexy group (94/295 at 12 months and 
134/317 at 24 months). Rates of continence and tenesmus 
were better in the traditional excisional surgery group than in 
the stapled haemorrhoidopexy group; complications were 
similar in both groups. Pain and analgesic use were lower in the 
stapled haemorrhoidopexy group in the ﬁ rst 3 weeks after 
surgery, but time to return to normal activity 6 weeks after 
surgery was similar between groups. No diﬀ erence was 
observed in length of stay or operating time between 
groups. Traditional excisional surgery was found to be more 
cost-eﬀ ective than stapled haemorrhoidopexy terms of 
cost-eﬀ ectiveness.
Implications of all the available evidence
The results of this study show that although both stapled 
haemorrhoidopexy and traditional excisional surgery are 
equally safe, traditional excisional surgery has better quality of 
life and is associated with fewer symptoms and recurrence of 
haemorrhoids. Additionally, stapled haemorrhoidopexy is more 
expensive and is not cost-eﬀ ective. 
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previous surgical treatment for anal sphincter injury 
repair, or had symptomatic incontinence or peri-anal 
sepsis. Those with known inﬂ ammatory bowel disease or 
malignant gastrointestinal disease, within the past 5 years, 
or who were deemed medically unﬁ t for surgery, were also 
ineligible, as were pregnant women. The exclusion criteria 
were set to have a minimum eﬀ ect on the overall numbers 
of participants recruited to the trial and hence maximise 
generalisability. The study was approved by the North of 
Scotland Research Ethics Committee on June 18, 2010 
(reference number 10/20802/17). The protocol was 
published in 2014.15
Randomisation and masking
Participants were randomly assigned (1:1) to receive 
either traditional excisional surgery or stapled 
haemorrhoidopexy with the use of an automated system 
with telephone and web-based interfaces run from the 
trial oﬃ  ce. The randomisation minimisation algorithm 
used included centre, grade of haemorrhoidal disease 
(II, III, or IV), baseline EuroQol 5 dimensions 3 level 
(EQ-5D-3L) descriptive system score,16 and sex. Patients 
and investigators were not masked to treatment 
allocation.
Procedures
Participants were recruited by surgeons and research 
nurses in the outpatient department. The surgeons and 
research nurses were also responsible for initiating 
randomisation. Eligible and consented participants were 
placed on the appropriate waiting list by the treating 
colorectal surgeon or a designated team member. 
The EQ-5D-3L UK wording and population norms 
(range –0·59 to 1·0, with 1·0 being optimum),16 36-item 
Short Form Health Survey (SF-36) version 2 score, 
Cleveland incontinence score (CIS; range 0–20, with 
0 being optimum), and Haemorrhoid symptom score 
(HSS; 0–26 range, with 0 being optimum) were collected 
pre-randomisation as baseline measures.17,18 Other data 
collected at baseline included height, weight, grade of 
haemorrhoid, anticoagulant medication prescriptions, 
and previous treatments for haemorrhoids. Each centre’s 
participating surgeons had received appropriate 
recognised training for both stapled and traditional 
haemorrhoid surgery and were using the procedures 
routinely in their hospitals. Surgery was only done by 
surgeons in the late stage of training if they had been 
signed oﬀ  by their supervising consultant surgeon, or if 
they were operating under the direct supervision of their 
consultant. Preoperative and postoperative care followed 
the respective surgeon’s and NHS hospital’s standard 
policies. Stapled haemorrhoidopexy aims to correct 
haemorrhoidal prolapse by excising a ring of tissue above 
the haemorrhoidal cushions with immediate re-
anastomosis of the mucosa with the use of staples. 
A secondary eﬀ ect might be to reduce blood ﬂ ow and 
therefore congestion. Fibrosis develops at the staple line 
maintaining the haemorrhoids in their new position. 
Stapled haemorrhoidopexy is done with the use of a 
stapling gun. Three haemorrhoid stapling devices are 
commonly in use within the UK (Johnson & Johnson, 
Chex, and Covidien). Reﬂ ecting the pragmatic nature of 
the trial, surgeons were able to use the gun which they 
normally use in their routine practice.
There are two commonly used traditional excisional 
procedures done across the world: open19 and closed.20 
Both have the intention of excising the haemorrhoidal 
cushions. The procedure is most commonly done with 
electrocautery. In this trial, surgeons undertook whichever 
procedure they would do as part of their routine practice. 
The use of the Ligasure Medtronic (Minneapolis, MN, 
USA) and Harmonic Ethicon Johnson and Johnson (NJ, 
USA) devices to perform an excisional haemorrhoidectomy 
were excluded in this trial. On the day of surgery, the grade 
of surgeon and anaesthetist and the type of anaesthesia 
and the surgical technique were recorded. Additionally, the 
length of time the procedure took and any intraoperative 
complications were recorded. Data for postoperative 
complications before discharge, which included post-
operative bleeding, pelvic sepsis, the need for blood 
transfusion, and urinary retention were collected.
Participants were followed up for 24 months; this 
consisted of a single clinic visit followed by multiple 
postal questionnaires completed by the participant. 
Routine data were also used to measure recurrence and 
further treatment. At the 6 week clinic appointment, data 
for postoperative complications including haemorrhage, 
requirement for blood transfusion, anal stenosis, 
anal ﬁ ssure, urinary retention (which required 
catheterisation), residual anal skin tags, diﬃ  cult 
defecation, wound discharge, pelvic sepsis, and pruritus 
were collected. Clinical examination of the anal canal was 
not routinely performed. Further haemorrhoid-related 
interventions since discharge and the need for further 
planned medical and/or surgical treatments for 
haemorrhoids or complications associated with treat-
ment were recorded. Postoperative examination of the 
anal canal during the 6 week follow-up clinic was 
included in the protocol but was not done routinely if 
patients reported that their symptoms were improving. 
This is in line with current practice and was also adhered 
to in the HubBLe trial.
EQ-5D-3L and visual analogue scale (VAS) pain data 
were collected by postal questionnaire at 1 and 3 weeks 
after surgery. EQ-5D-3L, SF-36, HSS, CIS, and VAS data 
were collected by postal questionnaire at 6 weeks 
after surgery. Additionally, questionnaires distributed at 
12 and 24 months after randomisation also collected data 
for patient-reported haemorrhoid recurrence and further 
operations. Participants who did not respond to 12 and 
24 month questionnaires were sent a postal reminder 
and a shortened version of the questionnaire containing 
the EQ-5D-3L only. The main outcome assessment was 
planned at 24 months (from the date of randomisation) 
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follow-up. Consent was sought from all participants to be 
ﬂ agged for notiﬁ cation of haemorrhoidal recurrence. To 
assess long-term safety, the participants were investigated 
for further haemorrhoidal surgery through Hospital 
Episode Statistics (HES) in England, Patient Database 
Wales (PEDW) in Wales, and Information Services 
Division (ISD) data in Scotland, when all participants 
had reached 12 months post-randomisation.
Outcomes
The primary outcome was the area under the quality of 
life curve (AUC) over 24 months derived from 
EQ-5D-3L measurements taken from patient question-
naires distributed at baseline, 1 week, 3 weeks, 6 weeks 
(postoperative), 12 months, and 24 months post-
randomisation. The AUC is expressed in years and can be 
interpreted as quality-adjusted life-years (QALYs). The 
primary trial economic outcome was incremental costs per 
QALY gained with QALYs based on the responses to the 
EQ-5D-3L over 24 months. Patient-reported secondary 
outcomes were generic health proﬁ le measured by SF-36 
and EQ-5D-3L, VAS pain score, CIS, HSS, postoperative 
analgesia consumption, recurrence of haemorrhoids, and 
tenesmus. Tenesmus can be a disabling symptom which is 
described as a feeling of wanting to pass stool, even though 
the rectum is empty. The clinical secondary outcomes were 
further interventions, intraoperative and postoperative 
complications including haemorrhage, requirement for 
blood transfusion, anal stenosis, anal ﬁ ssure, urinary 
retention (which required catheterisation), residual anal 
skin tags, diﬃ  cult defecation, wound discharge, pelvic 
sepsis, and pruritus. A serious adverse event was deﬁ ned 
as an event occurring to a research participant that was 
treatment related (resulted from administration of any of 
the research procedures) and was expected or unexpected 
that caused death, was life threatening, required hospital 
admission, resulted in signiﬁ cant incapacity or disability, 
or was otherwise considered medically signiﬁ cant by the 
investigators. Death, related or not to the study treatment, 
was also recorded.
Statistical analysis
A sample size of 338 per group was required to provide 
90% power to detect a diﬀ erence in the mean area under 
the quality of life AUC curve of 0·25 SDs derived from 
EQ-5D-3L score measurements, with a signiﬁ cance 
level of 5% (two-sided α). Data for the  EQ-5D-3L AUC, 
in this patient group, were limited at the time of study 
conduct but an SD of 0·25 was thought to be suﬃ  cient 
to detect a worthwhile diﬀ erence in quality of life 
measures. To allow for 15% non-response in the 
outcome, we randomly assigned 400 patients in each of 
the two groups. Such a sample size would also provide 
1127 patients screened
71 ineligible
1056 eligible patients
777 patients randomly assigned
279 excluded 
225 declined
33 clinical reasons   
21 missed
389 assigned to stapled 
haemorrhoidopexy 
388 assigned to traditional 
excisional surgery 
1 post-randomisation
exclusion
2 post-randomisation 
exclusions
388 had clinical assessment 
at baseline
388 responded to questionnaire 
at baseline
386 had clinical assessment 
at baseline
386 responded to questionnaire
358 had surgery
301 had stapled 
haemorrhoidopexy
37 had traditional 
excisional surgery
18 had other surgical 
technique
2 unknown 
363 had surgery
323 had traditional 
excisional surgery 
29 had stapled 
haemorrhoidopexy 
11 had other surgical 
technique
7 withdrew before surgery
0 died before surgery
16 did not receive surgery
8 withdrew before surgery
1 died before surgery
21 did not receive surgery
Follow-up 1 week after surgery
296 completed questionnaire
3 withdrew
Follow-up 3 weeks after surgery
282 completed questionnaire
3 withdrew
Follow-up 6 weeks after surgery
357 had clinical assessment
305 completed questionnaire
5 withdrew
Follow-up 6 weeks after surgery
347 had clinical assessment
309 completed questionnaire
2 withdrew
Follow-up 12 months after 
randomisation
278 completed questionnaire
14 withdrew
0 died
Follow-up 24 months after 
randomisation
274 completed questionnaire
16 withdrew
 0 died
275 included in primary analysis
Follow-up 1 week after surgery
301 completed questionnaire
0 withdrew
Follow-up 3 weeks after surgery
291 completed questionnaire
1 withdrew
Follow-up 12 months after 
randomisation
295 completed questionnaire
11 withdrew
2 died
Follow-up 24 months after 
randomisation
288 completed questionnaire
15 withdrew
2 died
295 included in primary analysis
Figure 1: Trial proﬁ le
Numbers of participants declining further follow-up or not responding to the 
questionnaire are cumulative in direction of participant ﬂ ow.
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90% power to assess diﬀ erences in the secondary 
outcome of recurrence between the two surgical 
techniques from around 10% to around 4%. This 
magnitude of diﬀ erence was supported by a systematic 
review,9 which showed a higher recurrence in the 
stapled haemorrhoidopexy group compared with the 
traditional excisional surgery group, but this was not 
statistically signiﬁ cant. No adjustment in sample size 
was made for the potential gain in precision due 
to adjustment for the baseline EQ-5D-3L score, 
haemorrhoid grade, or sex.
Study analyses followed a comprehensive, prespeciﬁ ed 
statistical analysis plan. The main statistical analyses 
were based on all participants as randomised, irrespective 
of subsequent compliance with treatment allocation. 
Prespeciﬁ ed subgroup analyses investigated the 
inﬂ uence of haemorrhoidal grade and sex with the use of 
treatment by subgroup interaction eﬀ ects. The primary 
outcome measure was analysed with linear regression 
adjusting for the other minimisation variables as ﬁ xed 
eﬀ ects with the exception of centre, which was accounted 
for using cluster robust standard errors. The preplanned 
principal analysis included participants with at least one 
short-term post-surgery follow-up (1, 3, or 6 weeks) and 
at least one long-term measurement (12, 18, or 
24 months), to calculate the AUC. Sensitivity analyses 
included all participants with a long-term measure. 
Secondary analyses of the primary outcomes explored 
sensitivity to assumptions regarding interpolation, 
missing data (using multiple imputation by chained 
equations using the “ice” Stata command21 to impute the 
missing EQ-5D-3L scores 30 times before calculating the 
AUC and then using Rubin’s rule to combine and 
estimate), and also compliance (using a per-protocol 
population consisting of those who received the allocated 
intervention). The EQ-5D-3L AUC over 6 weeks and 
12 months was also compared. The secondary outcome 
tenesmus was analysed with the χ² test for trend, further 
surgical intervention was analysed with the χ² test. The 
other secondary outcomes were analysed with generalised 
linear models (ie, logistic regression) or linear mixed 
models with adjustment for the minimisation variables. 
Continuous variables were summarised with mean (SD) 
or median (IQR) whereas discrete variables were reported 
as absolute number and percentage in each category. All 
analyses were assessed at the two-sided 5% signiﬁ cance 
level except for the subgroups which were assessed at 
two-sided 1% level.
A cost-eﬀ ectiveness analysis in terms of incremental 
cost per QALYs gained was undertaken. The costs of the 
interventions were estimated by identifying, measuring, 
and valuing resource use. Resource use was identiﬁ ed 
and measured from case report forms and patient-
reported questionnaires and was valued with published 
source such as NHS reference costs.22 All costs were 
estimated from the NHS and personal social perspective 
as per National Institute for Health and Care Excellence 
recommendations. As patients were followed up for 
more than a year, costs and QALYs were discounted at 
the recommended rate of 3·5%.23 The economic data 
analysis accounted for missing data using multiple 
imputation. Both the statistical and the economic 
analyses were done using Stata, version 14. This trial 
is registered with the ISRCTN registry, number 
ISRCTN80061723.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication.
Results
Between Jan 13, 2011, and Aug 1, 2014, 1127 patients were 
screened for eligibility. Of these, 777 were randomly 
assigned to either receive stapled haemorrhoidopexy 
(n=389) or traditional excisional surgery (n=388; 
ﬁ gure 1). 774 participants were included in the analysis as 
Stapled 
haemorrhoidopexy 
(n=388)
Traditional excisional 
surgery (n=386)
Baseline characteristics
Age (years) 50 (40–60) 49 (40–59)
Sex
Male 201 (52%) 197 (51%)
Female 187 (48%) 189 (49%)
Body-mass index 27·0 (5·2); 372 27·0 (4·9); 367
Grade of haemorrhoid
II 86 (22%) 86 (22%)
III 243 (63%) 240 (62%)
IV 59 (15%) 60 (16%)
Previous haemorrhoid 
treatment*
139 (36%) 116 (30%)
Pain (visual analogue 
score)†
2·8 (2·7); 379 2·5 (2·6); 383
EQ-5D-3L‡ 0·764 (0·264); 388 0·762 (0·246); 386
Cleveland incontinence 
score
4·3 (3·9); 376 4·1 (4·0); 376
Haemorrhoid symptom 
score
10·8 (4·7); 370 10·4 (4·7); 370
Operative details
Duration of operation (h) 0·4 (0·2); 346 0·4 (0·2); 359
Length of hospital stay 
(days)
0·4 (0·3); 356 0·4 (0·4); 363
Day cases 305/356 (86%) 317/363 (87%)
Time to surgery (days) 68·2 (78·3); 358 68·8 (81·1); 363
Data are median (IQR), n (%), or mean (SD); N. EQ-5D-3L=EuroQol 5 dimensions 
3 level. *Previous haemorrhoid treatment refers to rubber band ligature or 
haemorrhoidal artery ligation. †Scale range is from 0 (no pain) to 10 (worst 
imaginable pain). ‡The EQ-5D-3L index ranges from –0·59 to 1·0, with positive values 
indicating a perfect outcome and negative values imply states worse than death.  
Table 1: Baseline characteristics and operative details
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three participants were excluded after randomisation; 
one from the stapled haemorrhoidopexy group and two 
from the traditional excisional surgery group. The trial 
was terminated on July 8, 2016. Median follow-up was 
731 days (IQR 377–736) for the stapled haemorrhoidopexy 
group and 731 days (514–738) for the traditional excisional 
surgery group. Baseline questionnaire and clinical case 
report form data were available for all randomised 
participants (table 1). 721 participants received surgery, 
and, of these, 37 participants in the stapled 
haemorrhoidopexy group received traditional excisional 
surgery and 29 in the traditional excisional surgery group 
received stapled haem orrhoidopexy. The two main 
reasons for not receiving randomised treatment were 
surgeons’ decision after clinical examination and 
participant preference for surgery.
272 (84%) of 323 participants in the traditional 
excisional surgery group underwent the Milligan 
Morgan technique for excisional surgery. Most 
procedures were done under general anaesthesia 
(341 [95%] of 358 in the stapled haemorrhoidopexy group 
vs 350 [96%] of 363 in the traditional excisional surgery 
group), some with an additional local anaesthetic block 
(105 [29%] in the stapled haemorrhoidopexy group vs 
127 [35%] in the traditional excisional surgery group). 
256 (72%) of 358 participants were operated on by 
consultant surgeons in the stapled haemorrhoidopexy 
group compared with 225 (62%) of 363 in the traditional 
excisional surgery group. Surgical trainees performed 
58 (16%) of 358 stapled haemorrhoidopexy procedures 
and 89 (25%) of 363 traditional excisional surgeries. 
Specialty doctors per formed the remaining operations 
(32 [9%] of 358 in the stapled haemorrhoidopexy group 
vs 37 [10%] of 363 in the traditional excisional surgery 
group). No diﬀ erences were noted between the duration 
of the operation and the length of stay; time spent 
waiting for surgery was also similar between groups 
(table 1).
The EQ-5D-3L proﬁ le for the two treatment groups 
is shown in ﬁ gure 2. Participants in the stapled 
haemorrhoidopexy group had higher EQ-5D-3L scores 
than those in the traditional excisional surgery group at 1 
and 3 weeks whereas the EQ-5D-3L scores were higher in 
the traditional excisional surgery group than the stapled 
haemorrhoidopexy group from 6 weeks onwards. The 
primary outcome, EQ-5D-3L AUC over 24 months was 
higher in the traditional excisional surgery group: mean 
diﬀ erence –0·073 (95% CI –0·140 to –0·006); the AUC 
over 12 months post-randomisation showed no diﬀ erence 
between the two interventions. Secondary analyses of 
EQ-5D-3L AUC at 24 months, which explored sensitivities 
to assumptions (per protocol) and multiple imputation 
analyses (appendix p 1), were consistent with the main 
analyses for all time horizons. Subgroup analyses of sex 
and grade of haemorrhoid did not reveal treatment eﬀ ect 
diﬀ erences in EQ-5D-3L AUC (appendix p 1). Both the 
physical and mental components of the SF-36 improved 
after surgical intervention, with participants in the 
traditional excisional surgery having signiﬁ cantly more 
improvement when compared with stapled haemorrhoid-
opexy at 12 months (table 2). This diﬀ erence was sustained 
at 24 months, but was not statistically signiﬁ cant.
While participants in the stapled haemorrhoidopexy 
group had a similar HSS score to the traditional 
excisional surgery group at 6 weeks (mean diﬀ erence 
0·15, 95% CI –0·60 to 0·91; p=0·69), it was higher at 
both 12 months (2·09, 1·28–2·90; p<0·0001), and 
24 months (1·46, 0·64–2·28; p=0·0005; table 2). 
Additionally, 295 participants in the stapled 
haemorrhoidopexy group and 278 in the traditional 
excisional surgery group responded to a question about 
whether their haemorrhoids had come back 12 months 
after randomisation. In the stapled haemorrhoidopexy 
group, 94 (32%) of 295 participants reported that their 
symptoms had returned compared with 39 (14%) of 
278 in the traditional excisional surgery group (odds ratio 
[OR] 2·96; 95% CI 2·02–4·32, p<0·0001), and this 
diﬀ erence was maintained at 24 months (table 3). 
Registry data (ISD/PEDW/HES, of which the following 
codes were ﬂ agged: H511, H513) and self-reports 
of further surgical interventions were combined. 
Self-reported and registry data were veriﬁ ed by contacting 
sites for all but six cases (because of time constraints we 
were unable to verify four cases and in two additional 
cases, the sites did not respond to our queries); data was 
Figure 2: AUC EQ-5D-3L score comparison between stapled haemorrhoidopexy and traditional excisional 
surgery groups
Participants need to have at least one short-term and one long-term follow-up score for inclusion in the primary 
analysis. Mean (SD); N is shown for 6 weeks, 12 months, and 24 months. ED-5D-3L AUC=EuroQoL 5 dimensions 
3 level area under a curve. A breakdown of the number of participants included at each timepoint in the analysis is 
given in the appendix (p 3).
6 weeks
12 months
24 months
0 0·5 1·0 1·5 2·0
Time since randomisation (years)
EQ
-5
D 
sc
or
e
0·215 (0·150); 331
0·824 (0·218); 282
1·556 (0·483); 295
Stapled 
haemorrhoidopexy
(n=388)
0·197 (0·143); 328
0·828 (0·225); 262
1·618 (0·431); 275
Traditional 
excisional surgery
(n=386)
0·020 (0·003 to 0·038)
–0·010 (–0·039 to 0·019)
–0·073 (–0·140 to –0·006)
Mean diﬀerence
(95% CI)
0·0235
0·48
0·0342
p value
0·5
0
0·6
0·7
0·8
0·9
Stapled haemorrhoidopexy
Traditional excisional surgery
See Online for appendix
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still included if the site did not conﬁ rm an intervention 
was done. If there was discrepancy between self-reported 
and registry data, self-reported data were used. A higher 
incidence of further surgery was reported in the stapled 
haemorrhoidopexy group compared with the traditional 
excisional surgery group (table 3).
Participant reported pain with VAS was signiﬁ cantly 
better in the stapled haemorrhoidopexy group at 1 and 
3 weeks after surgery than in the traditional excisional 
surgery group but no diﬀ erence between groups was 
noted at 6 weeks (appendix p 2). Analgesia use at 3 weeks 
was lower in the stapled haemorrhoidopexy group than 
in the traditional excisional surgery group (OR 0·58, 
95% CI 0·45–0·75, p<0·0001), but no diﬀ erence was 
reported at 1 and 6 weeks (appendix p 2). At 12 and 
24 months after randomisation, a signiﬁ cant diﬀ erence 
between CIS between treatment groups was noted; 
however, the scores were similar in both groups 6 weeks 
after randomisation (table 2). Participants were asked 
about the presence of tenesmus at 6 weeks, 12 months, 
and 24 months. Tenesmus was more prevalent in the 
stapled haemorrhoidopexy group throughout the follow-
up period (table 2).
Serious adverse events were reported by treatment 
received. 24 (7%) participants had a serious adverse event 
after undergoing stapled haemorrhoidopexy and 33 (9%) 
after receiving traditional excisional surgery (table 4). 
One participant died in the stapled haemorrhoidopexy 
group, but this death was unrelated to haemorrhoid 
surgery. Most hospital admissions were for pain, 
bleeding, constipation, and urinary retention. Only 
two participants received a blood transfusion 
(one participant had low concentration of haemoglobin 
before surgery and one participant was readmitted 1 week 
after surgery with severe postoperative bleeding, 
requiring an extensive hospital stay). 11 participants 
required catheterisation for urinary retention; seven had 
received traditional excisional surgery and four stapled 
haemorrhoidopexy. Ten participants remained in hospital 
or were readmitted with pain in the traditional excisional 
surgery group compared with six in the stapled 
haemorrhoidopexy group. A few participants had a 
combination of pain, constipation, and bleeding, but 
bleeding on its own was more common in the stapled 
haemorrhoidopexy group than in the traditional 
excisional surgery group. Two participants in each group 
reported pain caused by an anal ﬁ ssure. No episodes of 
pelvic sepsis or rectal perforation were recorded in 
this trial.
The mean cost per patient for stapled haemorrhoidopexy 
was £941 (SD 415) compared with £602 (507) for traditional 
excisional surgery (appendix p 3). The adjusted analysis 
mean diﬀ erence in total costs was £337 (95% CI 251–423) 
higher for stapled haemorrhoidopexy than for traditional 
excisional surgery. The QALY results for the stapled 
haemorrhoidopexy group were 1·62 (SD 0·43) and 1·69 
(0·38) for the traditional excisional surgery group. The 
adjusted analysis mean diﬀ erence in QALYs between 
groups was –0·070 (95% CI –0·127 to –0·011). Overall, 
stapled haemorrhoidopexy cost more than traditional 
excisional surgery and had a lower number of QALYs than 
traditional excisional surgery. The cost utility analysis 
indicated that stapled haemorrhoidopexy has <0·1% 
Stapled 
haemorrhoidopexy 
(n=388)
Traditional 
excisional 
surgery (n=386)
Eﬀ ect 
size
95% CI p value
Cleveland incontinence score
Baseline 4·3 (3·9); 376 4·1 (4·0); 376 ·· ·· ··
6 weeks 5·1 (4·5); 288 5·0 (4·3); 290 –0·16 (–0·74 to 0·42) 0·58
12 months 4·4 (4·3); 266 2·9 (3·5); 247 1·20 (0·58 to 1·81) 0·0001
24 months 3·8 (3·8); 249 3·0 (3·4); 235 0·79 (0·15 to 1·42) 0·0149
Haemorrhoid symptom score
Baseline 10·8 (4·7); 370 10·4 (4·7); 370 ·· ·· ··
6 weeks 8·2 (5·1); 288 7·9 (5·0); 291 0·15 (–0·60 to 0·91) 0·69
12 months 6·6 (5·1); 263 4·3 (4·3); 243 2·09 (1·28 to 2·90) <0·0001
24 months 6·4 (5·0); 250 4·8 (4·4); 240 1·46 (0·64 to 2·28) 0·0005
SF-36
Physical component summary
Baseline 48·5 (9·4); 380 48·8 (9·5); 377 ·· ·· ··
6 weeks 48·2 (10·4); 294 48·9 (9·2); 293 –0·58 (–1·77 to 0·61) 0·34
12 months 49·7 (10·1); 265 51·2 (9·4); 255 –1·79 (–3·06 to –0·51) 0·0059
24 months 50·3 (10·1); 250 51·1 (9·4); 234 –1·15 (–2·47 to 0·16) 0·0860
Mental component summary
Baseline 48·8 (11·7); 380 49·6 (11·0); 377 ·· ·· ··
6 weeks 47·3 (12·7); 294 48·7 (11·7); 293 –0·55 (–2·07 to 0·97) 0·48
12 months 48·8 (12·2); 265 51·2 (10·4); 255 –1·71 (–3·34 to –0·08) 0·0396
24 months 49·8 (11·2); 250 51·0 (10·9); 234 –0·89 (–2·57 to 0·80) 0·30
Tenesmus 
6 weeks
Participants 
followed up
309 305 ·· ·· 0·0010
Always 17 (6%) 9 (3%) ·· ·· ··
Often 42 (14%) 20 (7%) ·· ·· ··
Sometimes 82 (27%) 75 (25%) ·· ·· ··
Rarely 58 (19%) 68 (22%) ·· ·· ··
Never 109 (35%) 131 (43%) ·· ·· ··
Missing 1 (<1%) 2 (1%) ·· ·· ··
12 months
Participants 
followed up
295 278 ·· ·· <0·0001
Always 11 (4%) 4 (1%) ·· ·· ··
Often 27 (9%) 7 (3%) ·· ·· ··
Sometimes 60 (20%) 46 (17%) ·· ·· ··
Rarely 65 (22%) 43 (15%) ·· ·· ··
Never 113 (38%) 154 (55%) ·· ·· ··
Missing 19 (6%) 24 (9%) ·· ·· ··
24 months
(Table 2 continues on next page)
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probability of being cost-eﬀ ective at £20 000 and 0·1% 
probability of being cost-eﬀ ective at £30 000 willingness to 
pay threshold.
Discussion
The eTHoS trial showed that overall quality of life in the 
traditional excisional surgery group was better than the 
stapled haemorrhoidopexy group during the 24 month 
follow-up. On the basis of previous work on clinically 
important diﬀ erences in the EQ-5D-3L score, the 
magnitude of diﬀ erence in favour of traditional excisional 
surgery was clinically important (the equivalent of the 
quality of life being greater by a clinically important 
amount, for a full year). The minimum important 
diﬀ erence for the EQ-5D-3L has been estimated to be 
around 0·07 based on an anchor method applied to a 
range of patient populations.24,25 Additionally, participants 
in the traditional excisional surgery group reported fewer 
haemorrhoid incontinence symptoms, and recurrences. 
Stapled haemorrhoidopexy was less painful than 
traditional excisional surgery, but this diﬀ erence 
disappeared by 6 weeks. Short-term quality of life scores 
after surgery favoured stapled haemorrhoidopexy, 
reﬂ ecting the lower rates of pain in the immediate 
postoperative period. At 12 months, the EQ-5D-3L quality 
of life scores were similar between groups, however, the 
physical and mental health domains of the SF-36 
favoured the traditional excisional surgery group. 
At 24 months, the primary outcome favoured 
traditional excisional surgery. Additionally, less residual 
haemorrhoid symptoms and fewer recurrences and 
re-interventions were noted in the traditional excisional 
surgery group.
No diﬀ erences in the operating time, length of stay, or 
return to normal activity at 6 weeks were noted between 
the two procedures. This refutes the common argument 
that a shorter operating time and length of stay after 
stapled haemorrhoidopexy oﬀ sets the cost of a stapler 
and, taken alone, draws in to question the continued use 
of the technique. The continued use of stapled 
haemorrhoidopexy is further drawn into question by the 
other ﬁ ndings indicating a higher recurrence rate, more 
tenesmus, a higher cost, worse continence and equivocal 
complications. Even the reduced pain after stapled 
Stapled 
haemorrhoidopexy 
(n=388)
Traditional 
excisional 
surgery (n=386)
Eﬀ ect 
size
95% CI p value
(Continued from previous page)
Participants 
followed up
288 274 ·· ·· 0·0012
Always 6 (2%) 3 (1%) ·· ·· ··
Often 27 (9%) 13 (5%) ·· ·· ··
Sometimes 51 (18%) 36 (13%) ·· ·· ··
Rarely 55 (19%) 47 (17%) ·· ·· ··
Never 119 (41%) 143 (52%) ·· ·· ··
Missing 30 (10%) 32 (12%) ·· ·· ··
Data are n (%) or mean (SD); n. 6 weeks refers to time since sugery and 12 months and 24 months refers to time since 
randomisation. Eﬀ ect sizes are mean diﬀ erences. SF-36=36-item Short Form Health Survey. Always=one or more times 
daily. Often=more than once a week but less than once daily. Sometimes=more than once a month but less than once a 
week. Rarely=less than once a month. Missing=question not completed. 
 Table 2: Secondary outcomes
Stapled 
haemorrhoid-
opexy (n=338) 
Traditional 
excisional 
surgery 
(n=352) 
Participants who had a serious 
adverse event
24 (7%) 33 (9%)
Total number of serious adverse 
events
25 34
Infection 0 1 (<1%)
Urinary retention 4 (1%) 7 (2%)
Pain and bleeding 1 (<1%) 1 (<1%)
Pain and stenosis 1 (<1%) 0
Pain* 6 (2%) 10 (3%)
Stenosis 1 (<1%) 0
Constipation and urinary 
retention
0 2 (1%)
Bleeding 6 (2%) 1 (<1%)
Pain caused by ﬁ ssure 1 (<1%) 2 (1%)
Pain and constipation 0 1 (<1%)
Constipation 0 3 (1%)
Anaesthesia 0 2 (1%)
Constipation and bleeding 0 2 (1%)
Pain, constipation, and bleeding 0 1 (<1%)
Diﬃ  culty passing urine 2 (1%) 0
Haemorrhoids symptoms 1 (<1%) 0 
Fissure 1 (<1%) 0 
Data are n (%). *One participant in each group experienced two serious adverse 
events of pain.
Table 4: Serious adverse events by treatment received
Stapled 
haemorrhoidopexy 
(n=388)
Traditional 
excisional 
surgery 
(n=386)
Odds ratio 
(95% CI)
p value
Further surgical intervention 
24 months after randomisation
34/364 (9%) 23/371 (6%) ·· 0·11
Patients with registry data* 14 12 ·· ··
Patients with 
self-reported data*
26 15 ·· ··
Patient-reported recurrence
12 months after randomisation
Haemorrhoids reoccurred 94/295 (32%) 39/278 (14%) 2·96 (2·02–4·32) <0·0001
24 months after randomisation
Haemorrhoids reoccurred 134/317 (42%) 76/300 (25%) 2·25 (1·46–3·46) <0·0001
Data are n/N (%), unless otherwise speciﬁ ed. *Some participants had both registry and self-reported data. 
Table 3: Further surgical interventions and patient-reported recurrence
Articles
www.thelancet.com   Vol 388   November 12, 2016 2383
haemorrhoidopexy was equivalent to that in the 
traditional excisional surgery group 6 weeks post-
operatively.
Clinical recurrence of haemorrhoids was measured 
using HSS, a patient-reported dichotomous outcome 
measure, and recurrence data from national databases 
(ISD, HES, PEDW). Although the HSS has not been 
formally validated, the rationale for its use has been 
previously articulated14 and at the inception of the trial it 
was the best assessment tool available. We chose to 
assess recurrence over 24 months expecting to capture a 
proportion of patients who report symptom relapse 
after 12 months, and we found this to be the case. Little 
data are available concerning the long-term success 
rates of haemorrhoid surgery and after 24 months, 
distinguishing between symptoms caused by inadequate 
initial treatment and the occurrence of new disease 
would be important.10
Continence was an important outcome measure for this 
trial. The anal sphincter complex is comprised of two 
concentric muscles. Anal cushions (which form the basis 
of haemorrhoids) in the upper part of the canal contribute 
to continence by acting as washers helping to form a seal. 
Prolapsing haemorrhoids, therefore, interfere with this 
mechanism by disrupting the sealing mechanism of the 
sphincters and cushions working in concert. The 
traditional excisional surgery technique involves removing 
tissue close to the internal sphincter. Damage and therefore 
impairment of continence is widely reported after 
traditional excisional surgery.26 The optimum technique 
for stapled haemorrhoidopexy involves the accurate 
placement of the staple line 3–4 cm from the anal verge 
and therefore above the dentate line in the columnar 
mucosa of the anal canal. Staple lines lower than this 
might encroach on the more sensate squamous mucosa of 
the anal canal contributing to an increase in postoperative 
pain and a greater chance of injuring the internal 
sphincter.27 As expected, in the immediate postoperative 
period, CIS was impaired in both groups at 6 weeks when 
compared with baseline scores, explained by the presence 
of pain and healing. Thereafter, continence scores were 
signiﬁ cantly improved in the traditional excisional surgery 
group up to 24 months after randomisation. High quality 
surgery and the avoidance of sphincter injury in both 
groups, and a reduction in the volume of haemorrhoid 
tissue, could explain the slight improvement in continence 
scores over the course of the trial.
The economic analysis showed that traditional 
excisional surgery cost £337 less and had 0·07 more 
QALYs than the stapled haemorrhoidopexy group over 
the 24 month follow-up period. Stapled haemorrhoid-
opexy has a 0·1% probability of being considered cost-
eﬀ ective at the £30 000 threshold. Taken together with 
the HubBLe health-care cost analysis, both trials report 
that neither of the newer surgical techniques are 
cost-eﬀ ective. The results of the economic analysis diﬀ er 
from those published in the study by Burch and 
colleagues.7 In their study, Burch and colleagues reported 
that traditional excisional surgery and stapled 
haemorrhoidopexy had similar costs and QALYs, but 
that the costs of the staple gun were oﬀ set by savings in 
hospital stay. In our study, the inpatient stay was similar 
across both groups, so no cost saving in inpatient stay 
was reported, and our QALY results, on the basis of a 
24 month follow-up, indicated that stapled haemorrhoid-
opexy had lower QALYs than traditional excisional 
surgery. A paucity of robust economic data is available 
on haemorrhoid surgery, however, if the results of these 
contemporaneous trials are put into practice, substantial 
annual savings in publicly funded health services could 
be achieved.
Several decisions were made reﬂ ecting the pragmatic 
nature of the study’s conception and design and the aim to 
reﬂ ect routine care. First, the study was open label in that 
no attempt was made to mask participants (who were 
generally the outcome assessor) or the surgeon to treatment 
allocation. The presence or absence of peri-anal wounds 
would render masking impossible in the short term. No 
prescriptive entry criteria were set for hospital inclusion 
and we are therefore conﬁ dent that the results are 
generalisable across health services. A 24 month follow-up 
was used to capture symptom recurrence and further 
interventions; therefore, a median follow-up of 731 days 
was a further strength of this study. A pragmatic approach 
to surgeons’ credentials was used. At the inception of the 
trial, both techniques were established in common surgical 
practice and surgeons must have undergone appropriate 
recognised training for both procedures. Ideally, this will 
have included attendance at a masterclass. The eﬀ ect of 
surgical experience on outcomes can be partly mitigated by 
the high level of consultant involvement in performing the 
surgery and the low incidence of adverse events.
The trial had several limitations. As noted previously, 
participants and outcome assessors were not masked to 
treatment assignment which could have led to bias when 
measuring the subjective outcomes. Final recruitment 
to eTHoS was slightly short of the total target of 
800 participants and, furthermore, there were 
substantial, and greater than anticipated, missing data at 
24 months follow-up despite multiple strategies to 
mitigate this. This, perhaps, reﬂ ected the population 
(working age), the condition (chronic and considered by 
some to be a sensitive subject), and the nature of the 
follow-up. Nevertheless, the study still had suﬃ  cient 
statistical precision to detect diﬀ erences between 
treatment groups. Various secondary analyses explored 
plausible im putation and missing data assumptions 
regarding quality of life and a consistent pattern of 
beneﬁ t in favour of traditional excisional surgery was 
reported. A noticeable amount of non-compliance with 
allocation (some not receiving surgery, and some 
receiving a diﬀ erent operation) was noted reﬂ ecting 
perhaps a mixture of clinical reality and also some 
surgeon and patient preferences regarding treatment. 
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Such non-compliance tends to dilute a genuine eﬀ ect. 
We assessed the eﬀ ect of non-compliance in the per-
protocol population (appendix p 1). Despite this, the 
primary analysis still supported a diﬀ erence in favour of 
traditional excisional surgery, and the per-protocol 
analysis of only those who complied with allocation was 
consistent with this ﬁ nding. The delivery of the 
interventions reﬂ ected routine clinical practice across a 
range of centres in terms of the surgeons participating 
(their experience) and how the interventions were 
delivered (speciﬁ c technique, centre practices). Com-
parison of outcome between surgeons and surgical 
practice was diﬃ  cult in this context because of the 
numerous factors which aﬀ ect patients and centres 
which were not attributable to the surgeon. Taken 
together, we believe the ﬁ ndings are robust and 
generalisable. 
The interventions compared in eTHoS reﬂ ected clinical 
practice in the UK NHS at the time of its design. During 
the recruitment period a new intervention, haemorrhoidal 
artery ligation, started being used. The HubBLe trial 
showed no beneﬁ t for haemorrhoidal artery ligation over 
rubber band ligation.14 Together with eTHoS, these studies 
suggest a pattern of failure of new and purported better 
interventions to achieve suﬃ  cient clinical outcome at an 
appropriate cost. They provide a warning about the 
widespread adoption of expensive and unproven new 
procedures. The IDEAL framework28–30 provides a potential 
pathway from idea to robust assessment, though to date, 
while perhaps improving, surgical assesement is still often 
too late and not rigorous enough.
The introduction of new surgical treatments for 
haemorrhoids has been accompanied by the greater 
incidence of reporting of adverse events. Some of the 
published postoperative complications after surgery for a 
benign condition, have been severe, particularly with 
regard to pelvic sepsis, rectal perforation, and rectovaginal 
ﬁ stula formation.31 There were no reports of these 
complications within this trial, which might reﬂ ect safe 
surgical practice within trial centres or that complications 
occur more frequently within the earlier part of surgical 
learning curves. Serious adverse events were equally 
distributed in both groups. All the events were expected 
and largely consisted of pain, bleeding, constipation, and 
urinary retention.
The ﬁ ndings in this trial can be compared with a recent 
network meta-analysis,10 which included 98 trials of 
procedures for grade III and IV haemorrhoids in the 
analysis. The authors suggested that traditional excisional 
surgery was associated with fewer haemorrhoid 
recurrences and that stapled haemorrhoidopexy was 
associated with less postoperative pain and a higher rate 
of recurrence. However, the eTHoS trial refutes the data 
on higher complications rates, return to normal activity, 
length of operation, and length of stay in traditional 
excisional surgery. Taken together, the HubBLe and 
eTHoS trials, also answer the authors call for further 
high quality randomised controlled trials incorporating 
economic cost comparisons, and an updated network 
meta-analysis incorporating these two large trials would 
be appropriate.
Overall, traditional excisional surgery is both more 
clinically eﬀ ective and less costly when compared with 
stapled haemorrhoidopexy. It is more painful in the 
short term but this pain can be adequately managed at 
home. Time to return to normal activity was similar in 
both groups. In addition to superior quality of life 
measures, HSS, continence, and tenesmus rates and 
the need for further surgery were all lower with 
traditional excisional surgery. Traditional excisional 
surgery is, therefore, a superior surgical treatment to 
stapled haemorrhoidopexy for the management of 
grade II–IV haemorrhoids.
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